Hindustan Antibiotics Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 03-11-2024
- Paid Up Capital ₹ 71.72 Cr
as on 03-11-2024
- Company Age 70 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 343.97 Cr
as on 03-11-2024
About Hindustan Antibiotics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 71.72 Cr.
The company currently has active open charges totaling ₹343.97 Cr.
The Key Managerial Personnel (KMP) at Hindustan Antibiotics Limited India is Satish Kumar as COMPANY SECRETARY. Nirja Saraf, Richa Pandey, and Kaushalya serve as directors at the Company.
- CIN/LLPIN
U24231MH1954GOI009265
- Company No.
009265
- Company Classification
Private Limited Union Government Company
- Incorporation Date
30 Mar 1954
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hindustan Antibiotics Limited offer?
Hindustan Antibiotics Limited offers a wide range of products and services, including Personal Protective Equipment, Face Shield, Face Mask, Disposable Face Mask, Disposable Gloves, Surgical Gloves, Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Hindustan Antibiotics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirja Saraf  | Managing Director | 01-Oct-2016 | Current |
| Satish Kumar | Company Secretary | 21-Mar-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Richa Pandey | Nominee Director | 09-Dec-2022 | Current |
| Kaushalya | Director | 23-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Hindustan Antibiotics.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hindustan Antibiotics?
Unlock access to Hindustan Antibiotics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Karnataka Antibiotics And Pharmaceuticals LimitedActive 43 years 9 monthsNirja Saraf is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 29 Sep 2012 | ₹40.00 Cr | Open |
Central Bank Of India Creation Date: 12 Mar 2012 | ₹11.95 Cr | Open |
Vijaya Bank Creation Date: 11 Jan 2012 | ₹2.00 Cr | Open |
How Many Employees Work at Hindustan Antibiotics?
Unlock and access historical data on people associated with Hindustan Antibiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindustan Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Antibiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
